TERT-BUTYL (2-(5-PHENYL-4H-1,2,4-TRIAZOL-3-YL)ETHYL)CARBAMATE, 95.0%, 250mg

(1,4-Dioxan-2-yl)methanol, 95.0%, 1g

N-[(1R*,4R*)-4-Aminocyclohexyl]-3,3-dimethylbutanamide hydrochloride, 1g

1-Acetoxy-3-chloroacetone, 95.0%, 1g

rac-(3S,4S)-4-aminotetrahydro-2H-pyran-3-ol hydrochloride, 95.0%, 500mg

(R)-3-Amino-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 1g

tert-Butyl 2-bromobenzyl(methyl)carbamate, 96%, 1g

2-(Methylthio)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one, 96%, 50mg

Trial kit Spectra/Por® Biotech CE, 500–1000 dalton(s), 1 Piece(s)

2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-6-carboxylic acid, 97%, 250mg

5-(6-Bromo-2-fluoro-3-methoxyphenyl)oxazole, 98%, 500mg

Nickel powder 99.99% - 100 mesh 25 g

2-Methylenebutyrolactone (BHT added as stabilizer), 95.0%, 1g